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Background: Physical therapy is an essential component of multidisciplinary treatment in amyotrophic lateral sclerosis (ALS).
However, the meaning of physical therapy beside preservation of muscular strength and functional maintenance is not fully
understood.
Objective: The purpose of this study was to examine patients’ perception of physical therapy during symptom progression using
an internet assessment approach.
Methods: A prospective, longitudinal, observational study was performed. Recruitment took place in an ALS center in Berlin,
Germany. Online self-assessment was established on a case management platform over 6 months. Participants self-assessed the
progression of the disease with the ALS Functional Rating Scale-Revised (ALSFRS-R) and tracked the efficacy of targeted
physical therapy using Measure Yourself Medical Outcome Profile (MYMOP). We used the net promoter score (NPS) to inquire
into recommendation levels of physical therapy.
Results: Forty-five participants with ALS were included in the study. Twenty-seven (60.0%) started the online assessment. The
mean duration of physical therapy sessions per week was 142.7 minutes (SD 60.4) with a mean frequency of 2.9 (SD 1.2) per
week. As defined by MYMOP input, the most concerning symptoms were reported in the legs (62.2%), arms (31.1%), and less
frequently in the torso (6.7%). As expected for a progressive disease, there was a functional decline of 3 points in the ALSFRS-R
at the end of the observation period (n=20). Furthermore, the MYMOP showed a significant loss of 0.8 in the composite score,
0.9 in the activity score and 0.8 in the targeted symptom. In spite of functional decline, the recommendation for physical therapy
jumped from a baseline value of 20 NPS points to a very high 50 points at the end of study (P=.05).
Conclusions: Physical therapy is perceived as an important treatment method by patients with ALS. Despite functional
deterioration, patients are satisfied with physical therapy and recommend this intervention. The results also underline how the
meaning of physical therapy changes throughout the disease. Physical therapy in ALS has to be regarded as a supportive and
palliative health care intervention beyond functional outcome parameters.
(JMIR Rehabil Assist Technol 2018;5(2):e10099)   doi:10.2196/10099
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Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative
disease. The disease is characterized by a loss of motor neurons
in the cortex, brain stem, and spinal cord resulting in progressive
motor deficits and paralysis of the muscles that control limb
movement, swallowing, and breathing [1]. As the disease
progresses, muscles responsible for fine and gross motor
functions are affected, leading to a decline in motor skills. As
there is no current curative treatment for ALS, managing these
complex symptoms depends on multidisciplinary care.
Symptomatic, rehabilitative, and palliative therapy are typically
delivered by a multiprofessional team that consists of
neurologists, nurses, and therapists working in a coordinated
and organized manner [2]. An important part of this
multidisciplinary treatment is physical therapy, which is widely
prescribed and applied in the treatment of ALS. A European
survey has shown that 83% of ALS patients receive physical
therapy [3]. Physiotherapists play an essential role on the
multidisciplinary care team as they emphasize improving the
function and quality of life in patients who require physical and
functional dimensions of palliative care [4].
Experimental data [5-7] and several randomized clinical trials
showed moderate effects and benefits of submaximal resistive
exercises, especially in the early stages of the disease [8,9]. The
neuromuscular mechanism was thought to prevent disuse
atrophy and more efficient motor unit recruitment. Excessive
or high resistance exercises have been associated with overwork
damage and thus are not recommended in ALS treatment [8].
The key focus for physical therapists is to delay the decline of
muscular strength by submaximal resistance exercise, which
has been shown to be safe and efficacious. Additionally, because
pain and spasticity worsen the burden of ALS, physical therapy
also addresses these symptoms. Along with other service
providers, physical therapists support the provision and
adjustment of adaptive equipment and mobility aids [10].
However, there is still uncertainty about best practices
concerning the manner, duration, and frequency of physical
therapy. This lack of defined treatment guidelines arises from
the large clinical heterogeneity of ALS syndromes, the different
therapeutic approaches, and the individual expectations of
patients and therapists.
Thus, this study aimed to:
1. Evaluate the frequency and duration of physical therapy
sessions among ALS patients
2. Determine the most bothersome motor symptoms
3. Identify recommendation levels for physical therapy and
the Net Promoter Score (NPS) at the beginning and end of
the study
We investigated the recommendation of physical therapy to
symptom progression in ALS. Furthermore, we explored
whether the recommendation of physical therapy is related to
the most concerning motor symptom, disease severity, duration,
or the frequency of physical therapy sessions for ALS patients.
Methods
Study Design and Recruitment
This was a prospective, longitudinal, observational study that
recruited a consecutive cohort of participants from the ALS
outpatient department at Charité-Universitätsmedizin Berlin,
Germany. A baseline assessment of epidemiological data,
symptoms, type and amount of physical therapy was performed
with 45 individuals, 20 of whom completed online surveys over
a 6-months period, tracking symptom severity, restriction of
activity, and recommendation for physical therapy.
Setting
The digital and internet-supported case management network
Ambulanzpartner Soziotechnologie (APST) was used for online
self-assessment and evaluation of physical therapy [11]. APST
encompasses the services of case management coordinators, a
tailored digital management platform and assessment tools for
self-evaluation, services, therapy and assistive devices [12].
Patients and their caregivers were granted access to the APST
platform through personalized accounts.
Participants
Inclusion criteria for this study involved a possible, probable
or definitive diagnosis of ALS following the revised El Escorial
criteria [13], a stage of a disease where at least one motor
function was restricted, and participation in physical therapy.
Patients with other severe life-limiting diseases or who showed
clinically significant cognitive impairment were not eligible for
this trial. For online assessment, participants used the digital
case management program provided by APST [11].
Variables and Data Sources
Physical Therapy
Physical therapy was prescribed by a neurologist specializing
in ALS and undertaken by physical therapists trained in the
treatment of neurological disorders including ALS. In addition
to physical therapy, patients received special treatments such
as massages, lymphatic drainage, thermal treatment, and
breathing therapy if needed. The overall time and frequency of
individual physical therapy sessions per week were documented,
as were additional special treatments.
Amyotrophic Lateral Sclerosis Functional Rating
Scale-Revised
We evaluated the functional impairment of participants using
the ALS Functional Rating Scale-Revised (ALSFRS-R), through
online self-assessment [14]. This scale is a validated and widely
used instrument that gauges the fine and gross motor functions
of the arms and legs, bulbar functions, and breathing abilities.
It comprises 12 short, clear questions with 5 anchor points (0-4)
for response options. Hence, the total range of the scale spans
0 to 48 points, with fewer points representing poorer functioning
and higher disease severity. The loss of ALSFRS-R value per
month, or delta ALSFRS-R, indicates the rate of deterioration
and predicts survival [15].
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Measure Yourself Medical Outcome Profile
To focus on specific bothersome or disabling motor symptoms
we employed the Measure Yourself Medical Outcome Profile
(MYMOP) [16,17]. This instrument has not been used in patients
with ALS before but has been suggested as an individualized
patient-reported outcome measure in primary care physical
therapy [18]. The MYMOP is a brief, patient-generated,
problem-specific questionnaire, which requires participants to
specify a symptom that concerns them most. Subsequently,
participants evaluate the severity of this symptom on a 7-point
Likert scale (eg, weakness of the right leg could score 0 for “as
good as it could be” to 6 for “as bad as it could be”) as compared
to the previous week. The second part of the survey uses the
same scale to assess whether the symptom is limiting or
preventing a daily activity or movement, such as walking.
Participants also rate general well-being. Follow-up
questionnaires address the original concerns. All domains
(symptom severity, restriction of activity, and well-being) can
be analyzed individually or as a total score, the profile score,
that equals the mean of the subscores recorded (score 0-6).
Net Promoter Score
To evaluate the overall recommendation of physical therapy,
we used a numeric rating scale (NRS) that derives from the Net
Promoter Score (NPS) [19,20], which is used in customer
relation management and has recently been introduced to clinical
assessment [21,22]. The NPS is an easy-to-use, one-item
questionnaire that is based on the question “How likely is it,
that you would recommend the service to a friend or colleague?”
Participants were asked to score on a 0 to 10 NRS, with 10 being
extremely likely to recommend the therapy. The percentage of
participants whose response was between 0-6 was subtracted
from the percentage of those whose scores were 9-10 (Figure
1) to calculate the NPS. Participants with the values 7 and 8
were assumed to be indifferent or passive. Therefore, the NPS
can be as low as –100 if everybody is a detractor, or as high as
+100 if everybody is a promoter. A positive NPS is regarded
as good, and an NPS of more than 50 is considered excellent.
Alternatively, to avoid problems of NPS categorization, it is
possible to refrain from calculating the NPS and only report the
average NRS which reflects the recommendation [20].
Figure 1. Net Promoter Score calculation method: promoters (green), indifferent (yellow), and detractors (red).
Data Analysis
Data were analyzed with IBM SPSS Statistics (Version 24.0)
for Microsoft Windows. Results were expressed as mean (SD)
if normally distributed and medians (maximum/minimum) if
the distribution was non-Gaussian. Correlational analysis was
performed with the Spearman rho (ρ) because of the ordinal
nature of the scales. A statistically significant difference of
paired samples was analyzed with a t test. The recommendation
was tested with the Wilcoxon test for related samples. A P value
of <.05 (two-tailed) was considered significant. Due to the
observational design of the study, the data has not been adjusted
for multiple comparisons.
Protocol Approvals and Registrations
The study protocol was approved by the Medical Ethics
Committee of the Charité-Universitätsmedizin Berlin, Germany.
A data safety and monitoring board supervised the study. Signed
patient information and informed consent forms were obtained
from all participating patients.
Results
Descriptive Data
Forty-five participants were included in this study and performed
the baseline assessment. Sixty percent (27/45) also consented
to online assessment through MYMOP and the recommendation
of physical therapy for 20 weeks. Twenty of the 45 (44%)
participants finished the 20-week online assessment providing
complete data sets (Figure 2).
The mean age of all participants at baseline was 59.2 years (SD
10.6) with a relatively long disease duration of 27 months
(median min/max 3/203) due to a higher percentage of long-term
survivors in our trial. The mean duration of physical therapy
was 142.7 minutes per week (SD 60.4) and mean frequency
was 2.9 sessions per week (SD 1.2). Occupational therapy and
speech and language therapy are not included in these values.
The demographics and baseline characteristics of the participants
are presented in Table 1.
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Figure 2. Flowchart of participants.










59.9 (12.5)58.0 (5.6)59.4 (11.1)59.2 (10.6)Age (years), mean (SD)
Gender, n (%)
4 (20)3 (43)7 (35)16 (36)Female
16 (80)4 (57)20 (65)29 (64)Male
39.4 (1.0)36.1 (5.0)38.5 (4.8)36.9 (6.9)ALSFRS-Ra baseline, mean (SD)
0.53 (0.11)0.86 (0.27)0.61 (0.57)0.57 (0.51)Delta ALSFRS-Rb, mean (SD)
26.5 (3/195)16.0 (9/87)25.0 (3/194)27.0 (3/203)Disease duration (months), median (min/max)
2.9 (0.9)3.1 (1.1)3.0 (0.9)3.0 (0.9)Total MYMOPc baseline, mean (SD)
149.0 (62.7)157.1 (70.4)151.1 (63.5)142.7 (60.4)PTd time per week (minutes), mean (SD)
280.1 (120.7)216.6 (58.5)263.6 (110.7)269.3 (138.6)Overall time prescribed (minutes), mean (SD)
3.0 (1.2)2.9 (1.5)2.9 (1.2)2.9 (1.2)PT frequency per week, mean (SD)
aALSFRS-R: Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised.
bLoss of ALSFRS-R points per month.
cMYMOP: Measure Yourself Medical Outcome Profile.
dPT: physical therapy.
The Duration and Frequency of Physical Therapy
There was no significant difference between prescribed physical
therapy time and session frequency in the different baseline
cohorts. Given the fact that a regular physical therapy unit lasts
between 45 to 60 minutes and patients receive 3 units per week,
the mean duration of therapy sessions amounts to 2 and a half
to 3 hours per week. Interestingly, an additional 2 hours per
week were granted for special treatments. Only online
participants who completed the study prematurely received
fewer special treatment time of just 1 hour per week. However,
this did not reach statistical significance (P=.19).
Disease Progression and Functional Impairment
The ALSFRS-R at baseline was comparable with other trials,
but the ALS progression rate was 0.57 (SD 0.4), which is lower
than in an average ALS population where the loss is usually 0.8
to 0.9 of a point [23]. In the online cohort, the constant decline
in motor function was represented by an expected significant
decline in the total ALSFRS-R from 39.4 to 36.4 (P=.05).
The 18/45 (40%) patients who did not participate in the online
assessment showed a significantly more advanced stage of the
disease compared to those who attended (ALSFRS-R: 34.4
versus 38.5, P=.05). Seven of 45 (16%) participants withdrew
from the online survey after 7.7 weeks (SD 5.8). Among these
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participants a higher proportion was female (43% versus 20%)
and tended to be more affected (ALSFRS-R: 36.1 versus 39.4,
P=.13) with a higher rate of progression (delta ALSFRS-R: 0.72
versus 0.53, P=.19).
The Most Bothersome Symptom, Activity, and Well-Being
Based on the initial MYMOP questionnaire, 62% (28/45) of
participants defined symptoms in the legs as most bothersome,
while 31% (14/45) cited restrictions in their arms as the most
important issue. Three of the 45 participants (7%) named axial
symptoms like torso weakness as the dominating symptom
(Figure 3).
The total MYMOP of all cohorts at baseline was similar between
2.9 and 3.1. The profile score of MYMOP at baseline of 3.0
(SD 0.9, N=45) did not significantly correlate with the total
ALSFRS-R at baseline (r=.27, P=.17). Whereas the correlation
of the MYMOP with the according ALSFRS-R subscore related
to functional loss of arms and legs was significant (r=.45,
P=.003). However, the highest correlation was seen between
the ALSFRS-R lower extremities subscore and the MYMOP
symptom assessment subscore (r=.62, P<.001). This correlation
was reproducible throughout the trial.
In the online cohort (n=20, Table 2) the profile score of
MYMOP increased from 2.9 to 3.7 (P=.005). The MYMOP
subscores for activity increased from 3.1 to 4.0 (P=.02). The
burden of the target symptom increased from 3.1 to 3.9 (P=.02).
The well-being subscore displayed a strong trend towards poorer
well-being after 20 weeks (from 2.6 to 3.2) but without statistical
significance (P=.08).
The 7/27 (26%) online participants who withdrew initially
showed a poorer well-being subscore in the MYMOP as
compared to participants who finished the assessment (3.4 versus
2.6, P=.08).
Figure 3. Distribution of the most concerning symptom at baseline (N=45).
Table 2. Change over 20 weeks in the online cohort (n=20).
P valueaWeek 20, mean (SD)Baseline, mean (SD)Outcome parameter
<.00136.4 (1.3)39.4 (1.0)ALSFRS-Rb
.0053.7 (0.2)2.9 (0.2)MYMOPc, profile
.083.2 (0.3)2.6 (0.3)MYMOP, well-being
.024.0 (0.3)3.1 (0.2)MYMOP, activity
.023.9 (0.3)3.1 (0.2)MYMOP, symptom
.028.6 (0.3)7.6 (0.4)Recommendation
—5020NPSd
aWilcoxon test for related samples.
bALSFRS-R: Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised.
cMYMOP: Measure Yourself Medical Outcome Profile.
dNPS: Net Promotor Score.
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Recommendation Levels for Physical Therapy
The total value of the recommendation of physical therapy went
from 7.6 to 8.6 (P=.02, Figure 4). In the 7/45 (16%) withdrawing
participants, we could see a not statistically significant decrease
of recommendation based on the last assessment before
withdrawal: 7.4 (SD 2.2) versus 7.0 (SD 3.5).
The recommendation was not influenced by the factors (1) age,
(2) gender, (3) amount of physical therapy, (4) location of the
most concerning symptom, (5) degree of functional impairment,
and (6) well-being or activity (data not shown). Based on the
recommendation we calculated the NPS, which increased from
20 at the beginning to 50 at the end of the observation interval
(Figure 5).
Figure 4. Recommendation of physical therapy at week 1 and at week 20 (P<.05).
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Figure 5. Change in Net Promoter Score from week 1 to week 20.
Discussion
Principal Findings
This study aimed to determine patients’ perception of physical
therapy during disease progression. To our knowledge, there
are few systematic reports about the extent to which physical
therapy is applied to ALS patients. Baseline assessment of this
study revealed a mean duration of 269.3 minutes of prescribed
physical therapy including special treatments and a mean
frequency of three units per week. Our data did not show a
significant correlation between the recommendation of physical
therapy and the extent (duration and frequency) of its
application.
The ALS progression, measured by the ALSFRS-R, was
complimented by the MYMOP in order to show the effect of
motor decline on the perception of physical therapy. The
correlation between MYMOP and the motor domain of the
ALSFRS-R was strong, although this score is unable to measure
new or coexisting problems and concerns. The patient-centered
assessment was unable to measure other perceived benefits, like
the social and psychological meanings of physical therapy.
However, the studies found no evidence that declines in
well-being, motor function, or levels of activity significantly
degrade the overall recommendation of physical therapy.
Remarkably, throughout the study, the rating of physical therapy
improved in the majority of participants despite the functional
decline. As shown by the NPS rating of 20 in the first online
assessment, we found strong satisfaction with physical therapy.
By week 20 the NPS value reached a value of 50, which is
considered to be excellent and shows a high acceptance of
physical therapy within the studied cohort.
Limitations
Our findings must be considered in the context of their
limitations. Out of all 45 participants, male patients were
overrepresented in comparison to the general ALS population.
This inadequacy was exacerbated in the online cohort, which
we also have observed in previous online assessment trials. To
reduce this bias, we attempted to recruit participants offline.
However, women were more likely to terminate the assessment
early. The 7 participants who discontinued online-assessment
showed a trend towards faster progression, lower well-being
and lower recommendation of physical therapy. Presumably,
more aggressive disease progression might be a reason for
dropping out, as might discontent with physical therapy.
Measuring satisfaction using online self-assessment can be
challenging. The NPS enables patients to rate physical therapy
from the perspective of their own experience. At the same time,
it is a 1-dimensional questionnaire and therefore assumed to be
less reliable and more volatile than a composite index. In future
studies, multidimensional or open designs should be considered
to explore patients’ perspectives towards physical therapy in
greater depth.
Further limitations in the study were the single center
recruitment and the small sample size. Therefore, generalizations
must be made with caution. Our cohort was representative of
the ALS population regarding mean age and ALSFRS-R, but
the participants showed a longer mean disease duration. The
progression rate of 0.52 (SD 0.4) is lower than in an average
ALS population, which is because a wider range of disease
progression was represented as compared to homogenized
populations within pharmaceutical trials. We can imagine that
long-time survivors and patients whose diseases are progressing
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slowly will have a certain and eventually more positive attitude
towards physical therapy, even though the effect of therapy on
motor function might be considered more relevant in the early
stages of the disease. Finally, our population was seen at a
specialist center supported by a case management platform.
Furthermore, it is located in an advanced country with a
universal multi-payer health system where costs for physical
therapy are covered mostly by compulsory health insurances.
Consequently, our findings may not be broadly applicable to
other populations.
Conclusion
The overall positive assessment of physical therapy cannot be
fully explained with the established rehabilitative concept of
physical therapy. Our data suggest physical therapy plays an
important role in a palliative context, where therapy and
presumably the therapist hold considerable meaning for the
patient. Physical therapists serving as interdisciplinary team
members in palliative settings provide care for patients that
extend beyond physical and bodily aims. Embracing this concept
could entail shifting priorities across a disease continuum, and
changing the perception of physical therapists as well as other
allied health specialists [24]. Palliative and multidisciplinary
approaches should be encouraged during the education, training,
and qualification of physical therapists to implement the
changing perceptions of physical therapy.
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